Persistent Lack of Detectable HIV-1 Antibody in a Person with HIV Infection - Utah, 1995

Morbidity and Mortality Weekly Report

Volumn 45, Issue 9, 1996, Pages 181-185

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BIOSYNTHESIS; CASE REPORT; DISEASE TRANSMISSION; DNA SEQUENCE; ENZYME IMMUNOASSAY; EPIDEMIOLOGY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; UNITED STATES;

ADULT; AIDS SERODIAGNOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; UTAH;

EID: 0030574744     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-4.
2. Pau CP, Hu DJ, Spurill C, et al. Surveillance for HIV-1 group O infections in the United States. Transfusion 1996 (in press).
3. Farzadegan H, Polis MA, Wolinsky SM, et al. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study. Ann Intern Med 1988;108:785-90.
4. Roy MJ, Damato JJ, Burke DS. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 1993;269:2786-9.
5. Martin-Rico P, Pedersen C, Skinhoj P, Nielsen C, Lindhardt B. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man. AIDS 1995;9:95-6.
6. Soriano V, Dronda F, Gonzalex-Lopez A, Chaves F, Bravo R, Gutierrez M. HIV-1 causing AIDS and death in a seronegative individual. Vox Sang 1994;67:410-1.
7. Food and Drug Administration. Revised recommendations for the prevention of human immunodeficiency virus transmission blood and blood products [Memorandum to all registered blood and plasma establishments]. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1992.
8. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.
9. Food and Drug Administration. Recommendations for donor screening with a licensed test for HIV-1 antigen [Memorandum to all registered blood and plasma establishments]. Rockville Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1995.
10. CDC U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR 1996;45(no. RR-2).